The present disclosure describes microbial oil compositions that can include a biomass present in a culture medium. The biomass can include a microbial oil enriched in EPA. The present disclosure also describes methods of producing microbial oils enriched in EPA. The present disclosure also describes nutritional oil compositions including the microbial oils and nutritional oil concentrates prepared from the nutritional oil compositions or microbial oils.
A61K 31/202 - Acides carboxyliques, p.ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p.ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p.ex. acide linolénique
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
05 - Produits pharmaceutiques, vétérinaires et hygièniques
31 - Produits agricoles; animaux vivants
Produits et services
Mixtures of chemicals and microorganisms for increasing the
nutritional value of animal fodder other than for veterinary
use; biological preparations for use in the manufacture of
feed and feed additives; protein for use in the manufacture
of foodstuffs; proteins for the food industry; proteins for
use in animal feed and feed supplement manufacturing
processes; proteins for use in the manufacture of beverages;
protein for food for human consumption; proteins for use in
the manufacture of food products. Foods and foodstuffs intended for medical or veterinary use;
food supplements for humans and animals; dietary supplements
for humans and animals; protein supplements for humans and
animals; food for babies; veterinary preparations; feed
additives for animals; dietetic beverages adapted for
medical purposes; dietary supplement drinks. Foodstuffs for animals; additives to fodder; formula animal
feed not for medical purposes; animal fattening
preparations; animal beverages; pet beverages.
The present invention relates to a lactic acid bacteria composition, a process for the production of a lactic acid bacteria composition using such an additive composition, a starter culture or kit of parts comprising such lactic acid bacteria composition, a process for making a food or feed product, preferably a fermented milk product, using such lactic acid bacteria composition, and the use of such lactic acid bacteria composition in a process for making a food or feed product.
A23L 33/00 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement
A23L 3/00 - Conservation des aliments ou produits alimentaires, en général, p.ex. pasteurisation ou stérilisation, spécialement adaptée aux aliments ou produits alimentaires
C12N 1/00 - Micro-organismes, p.ex. protozoaires; Compositions les contenant; Procédés de culture ou de conservation de micro-organismes, ou de compositions les contenant; Procédés de préparation ou d'isolement d'une composition contenant un micro-organisme; Leurs milieux de culture
G16C 20/30 - Prévision des propriétés des composés, des compositions ou des mélanges chimiques
G06Q 50/00 - Systèmes ou procédés spécialement adaptés à un secteur particulier d’activité économique, p.ex. aux services d’utilité publique ou au tourisme
7.
PUFA-CONTAINING EDIBLE PRODUCT COMPRISING SHELL AND CENTER FILLING
The present invention relates to an edible product, such as a gummy or confection. In an embodiment, an edible product comprises a filling comprising a polyunsaturated fatty acid oil, an emulsifier, water, and a filling gelling agent, and a shell at least partially surrounding the filling. In an additional embodiment, the shell also comprises a bulking agent and en-capsulated particles comprising a coacervate shell encapsulating a polyunsaturated fatty acid.
A23L 2/84 - Clarification ou affinage des boissons non alcoolisées; Elimination des matières non désirées utilisant des micro-organismes ou un matériau biologique, p.ex. enzymes
Disclosed herein are compositions produced from microorganisms that are capable of producing high levels of docosapentaenoic acid (DPA(n-3)), and methods for producing the compositions. The invention is further directed to microbial strains and derivatives therefrom, biomasses, and microbial oils.
A61K 31/202 - Acides carboxyliques, p.ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p.ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p.ex. acide linolénique
The present invention relates to a rapeseed protein hydrolysate comprising protein fragments, wherein at least 50% (w/w) of the protein fragments has a molecular weight of less than 3.5 kDa.
A23J 1/00 - Préparation des compositions à base de protéines pour l'alimentation; Ouverture des œufs par grandes quantités et séparation du jaune du blanc
A23J 3/34 - Traitement des protéines pour l'alimentation par hydrolyse utilisant des agents chimiques utilisant des enzymes
The present invention relates to water-soluble or water-dispersible granules that are obtainable by continuous melt granulation. The granules comprise at least one binder, at least one filler and at least one active ingredients. Torque overload may be avoided when using a combination of the herein disclosed filler (e.g. mannitol or an HIMO) and binder (e.g. sorbitol).
A61K 47/26 - Hydrates de carbone, p.ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharides; Leurs dérivés, p.ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine
12.
SYSTEM AND METHOD FOR GENERATING A RECIPE FOR A THERMOPLASTIC COMPOUND
A processor system and method (100) are provided for generating a recipe for a thermoplastic compound, wherein the recipe defines a set of ingredients and a relative contribution of the ingredients for manufacturing the thermoplastic compound. The ingredients may comprise additives to be added to a base polymer. The recipe may be generated by training (110) a machine learnable model on compound data (20) of existing (historical) compounds to predict values of compound material properties from an input recipe, providing (120) candidate recipes, selecting 1 (40) a best recipe based on a scoring function, outputting (150) the selected recipe, e.g., via a display, to enable a sample of the compound to be manufactured (200) and measured (210), receiving (160) measurement data of the sample and determining a deviation to a target specification, and determining (170) if the recipe is acceptable. If the recipe is not acceptable, the machine learned model may be retrained or updated based on the measurement data and the recipe of the sample and the above-identified steps may be repeated until a recipe meets the target specification.
The present invention relates to water-soluble or water-dispersible granules that comprise a binder, a filler and an active ingredient. Preferred granules of the invention are obtained by continuous melt granulation of a mixture that comprises 65-70 weight-% active ingredient. 15-25 weight-% filler and 5-15 weight-% binder, based on the total weight of the mixture. Ascorbic acid and edible salts thereof are the preferred active ingredients.
A23P 10/25 - Agglomération ou granulation par extrusion ou par compression, p.ex. par des petits trous, des tamis ou entre des surfaces
A23L 29/30 - Aliments ou produits alimentaires contenant des additifs; Leur préparation ou leur traitement contenant des hydrolysats d'amidon, p.ex. de la dextrine
The present application relates to a texture improver. The texture improver comprises curdlan and rapeseed protein at a weight ratio of 1:9 to 9:1. When used in food, particularly in a meat product or a plant-based meat product, the texture improver can remarkably improve the texture and taste of the product, and meets clean food label requirements.
The invention relates to a process for augmenting the protein content of rapeseed protein meal, and to a composition useful in a process for improving the protein content of rapeseed protein meal.
A23J 1/14 - Préparation des compositions à base de protéines pour l'alimentation; Ouverture des œufs par grandes quantités et séparation du jaune du blanc à partir des tourteaux ou des graines oléagineuses
A23J 3/34 - Traitement des protéines pour l'alimentation par hydrolyse utilisant des agents chimiques utilisant des enzymes
A23K 10/14 - Prétraitement de produits alimentaires avec des enzymes
A23K 10/30 - Produits alimentaires pour animaux à base de matières d’origine fongique, p.ex. de champignons
A23K 20/147 - Dérivés polymériques, p.ex. peptides ou protéines
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
Produits et services
Additives for food and beverages, namely DHA algae oil
(docosahexaenoic acid) extracted from algae strains;
cultures and fermented preparations of microorganisms for
industrial use for the production of food, beverages, namely
DHA algae oil (docosahexaenoic acid) extracted from algae
strains; microbiologically produced products for industrial
use for the production of food, beverages, namely DHA algae
oil (docosahexaenoic acid) extracted from algae strains;
additives for food manufacturing, namely DHA algae oil
(docosahexaenoic acid) extracted from algae strains; fatty
acids for food manufacturing, namely DHA algae oil
(docosahexaenoic acid) extracted from algae strains; plant
extracts, other than essential oils, for the food industry,
namely DHA algae oil (docosahexaenoic acid) extracted from
algae strains.
17.
GRANULE COMPRISING ENCAPSULATED ACTIVE INGREDIENTS
The present invention relates to water-soluble or water-dispersible granules that are obtainable by continuous melt granulation. In an embodiment, the granules comprise at least one binder, at least one filler and microcapsules that encapsulate fat-soluble active ingredients.
The present invention relates to improved formulations of propandiol mononitrate and derivatives thereof as well as to the methods for production of such formulations.
C07C 403/04 - Dérivés du cyclohexane ou d'un cyclohexène, comportant une chaîne latérale avec une partie non saturée d'au moins quatre atomes de carbone en ligne, ladite partie étant directement attachée aux cycles cyclohexane ou cyclohexène, p.ex. vitamine A, bêt ayant des chaînes latérales substituées par des atomes d'halogène
C07C 403/24 - Dérivés du cyclohexane ou d'un cyclohexène, comportant une chaîne latérale avec une partie non saturée d'au moins quatre atomes de carbone en ligne, ladite partie étant directement attachée aux cycles cyclohexane ou cyclohexène, p.ex. vitamine A, bêt ayant des chaînes latérales substituées par des cycles non aromatiques à six chaînons, p.ex. bêta-carotène
20.
ELECTROCHEMICAL OXIDATION OF COMPOUNDS HAVING ALLYLIC C-H BONDS TO YIELD ALPHA,BETA-UNSATURATED KETONES
The present invention relates to the electrochemical oxidation of allylic C- H bonds in specific compounds to obtain specific α,β unsaturated ketones in the presence of t-butyl hydroperoxide. This process is particularly suitable for the electrochemical oxidation of cholesterol, stigmasterol, campesterol, β-sitosterol, brassicasterol, 25-hydroxycholesterol, 24-hydroxycholesterol, lanosterol, pregnenolone, and the esters thereof.
C07J 1/00 - Stéroïdes normaux contenant du carbone, de l'hydrogène, un halogène ou de l'oxygène, non substitués en position 17bêta par un atome de carbone, p.ex. œstrane, androstane
C07J 71/00 - Stéroïdes ayant le squelette du cyclopenta[a]hydrophénanthrène condensé avec un hétérocycle
The present invention relates to a process for the electrochemical oxidation of allylic C-H bonds in specific compounds to obtain specific α,β-unsaturated ketones.
The present disclosure discloses the identification and introduction of a specific heterologous gene (denoted as smob), which encodes an α-1,2-fucosyltransferase, into an LNT production strain to produce LNFP-I in particular.
The present disclosure discloses the identification and introduction of a specific heterologous gene (denoted as smob), which encodes an α-1,2-fucosyltransferase, into an LNT production strain to produce LNFP-I in particular.
The smob gene originates from the organism Sulfuriflexus mobilis (https://www.dsmz.de/collection/catalogue/details/culture/DSM-102939), which is a sulfur-oxidizing bacterium isolated from a brackish lake sediment.
The present disclosure discloses the identification and introduction of a specific heterologous gene (denoted as smob), which encodes an α-1,2-fucosyltransferase, into an LNT production strain to produce LNFP-I in particular.
The smob gene originates from the organism Sulfuriflexus mobilis (https://www.dsmz.de/collection/catalogue/details/culture/DSM-102939), which is a sulfur-oxidizing bacterium isolated from a brackish lake sediment.
FIG. 1 should accompany the abstract.
C12N 9/26 - Hydrolases (3.) agissant sur les composés glycosyliques (3.2) agissant sur les liaisons alpha-glucosidiques-1, 4, p.ex. hyaluronidase, invertase, amylase
C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
C12P 19/18 - Préparation de composés contenant des radicaux saccharide préparés par action d'une transférase glycosylique, p.ex. alpha-, bêta- ou gamma-cyclodextrines
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
foodstuffs for animals; Additives to fodder; Formula animal feed not for medical purposes; Animal fattening preparations; Animal beverages; Pet beverages Mixtures of chemicals and microorganisms for increasing the nutritional value of animal fodder other than for veterinary use; Biological preparations for use in the manufacture of feed and feed additives; Protein for use in the manufacture of foodstuffs; Proteins for the food industry; Proteins for use in animal feed and feed supplement manufacturing processes; Proteins for use in the manufacture of beverages; Protein for food for human consumption; Proteins for use in the manufacture of food products Foods and foodstuffs intended for medical or veterinary use; Food supplements for humans and animals; Dietary supplements for humans and animals; Protein supplements for humans and animals; Food for babies; veterinary preparations; Feed additives for animals; Dietetic beverages adapted for medical purposes; Dietary supplement drinks
The present disclosure relates to the field of food. Herein disclosed is a method for preparing a non-animal protein food product or a cultured meat food product comprising adding a lactase protein preparation to an ingredient used in the preparation of said food product and processing the obtained lactase protein preparation and ingredient composition into a non-animal protein food product or a cultured meat food product.
A23J 3/20 - Protéines à partir de micro-organismes ou à partir d'algues unicellulaires
A23C 20/02 - Succédanés du fromage ne contenant ni constituants du lait, ni caséinate, ni lactose, en tant que sources de matières grasses, de protéines ou d'hydrates de carbone
A process for the production of a Lactobacillus rhamnosus, wherein the process comprises the steps of: a) fermenting the Lactobacillus rhamnosus in a lactose-free, preferably milk-free, medium in a fermentor, and removing a fermentation broth from the fermentor, wherein the fermentation is carried out at a temperature of equal to or less than 39°C, preferably equal to or less than 37°C and at a pH setpoint of equal to or less than 5.6, preferably equal to or less than 5.4; b) applying shear to the fermentation broth and optionally concentrating the fermentation broth. Compositions so obtained and use of such compositions.
A23K 10/18 - Ajout de micro-organismes ou de leurs produits d’extraction, p.ex. de protéines provenant d’organismes unicellulaires, à des compositions de produits alimentaires de micro-organismes vivants
A23L 33/135 - Bactéries ou leurs dérivés, p.ex. probiotiques
26.
NOVEL PROCESS FOR PRODUCING LACTOBACILLUS RHAMNOSUS
A process, for the production of a Lactobacillus rhamnosus and/or for the production of a composition comprising a Lactobacillus rhamnosus, wherein the process comprises the steps of: fermenting the Lactobacillus rhamnosus in a lactose-free, preferably milk-free, medium in a fermentor, and removing a fermentation broth from the fermentor, wherein the fermentation is carried out in the presence of ammonium acetate and wherein the fermentation medium comprises a sodiumhydroxide and/or potassiumhydroxide.
A process for the production of a Lactobacillus rhamnosus, wherein the process comprises the steps of: a) fermenting the Lactobacillus rhamnosus in a lactose-free, preferably milk-free, medium in a fermentor, and removing a fermentation broth from the fermentor, wherein the fermentation is carried out in the presence of acetate or a acetate salt; b) applying shear to the fermentation broth and optionally concentrating the fermentation broth. Compositions so obtained and use of such compositions.
The invention relates to the field of molecular diagnostics, more specifically to a kit for the detection and quantification of thermophilic bacteriophages in a dairy sample.
C12Q 1/70 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir des virus ou des bactériophages
The present disclosure relates to the production of oligosaccharides, especially Human milk Oligosaccharides (HMOs) using a genetically engineered cell which has decreased or total loss of function of phosphoglycerol transferase I and II and/or phosphoethanolamine transferase and/or glucans biosynthesis protein C to reduce oligosaccharide by-products and/or increase oligosaccharide production.
Disclosed herein are processes for obtaining a microbial oil comprising one or more polyunsaturated fatty acids (PUFAs) from one or more microbial cells by lysing the cells to form a lysed cell composition, treating the lysed cell composition to form an oil-containing emulsion and then recovering the oil from the oil-containing emulsion. Further disclosed herein is microbial oil comprising one or more PUFAs that is recovered from microbial cells by at least one process described herein.
Provided is a new process for producing an imidazolidine compound of formula (I), or a salt thereof, or a stereoisomer thereof, or a stereoisomeric mixture thereof. According to the process, an additional reduction reagent such as zinc is avoided and the imidazolidine compound of formula (I), or a salt thereof, or a stereoisomer thereof, or a stereoisomeric mixture thereof, is produced in a high yield and selectivity.
A process for the production of a Lactobacillus rhamnosus, wherein the process comprises the steps of: a) fermenting the Lactobacillus rhamnosus in a lactose-free, preferably milk-free, medium in a fermentor, and removing a fermentation broth from the fermentor, wherein the fermentation is carried out in the presence of calcium or a calcium salt; b) applying shear to the fermentation broth and optionally concentrating the fermentation broth. Compositions so obtained and use of such compositions.
The present invention relates to industrial animal production. In particular the present invention relates to a method of raising a group of animals, and a method of determining analytes, in egg yolk or in the blood of an animal by ex vivo analysis of blood and/or yolk samples.
G01N 33/68 - Analyse chimique de matériau biologique, p.ex. de sang ou d'urine; Test par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligands; Test immunologique faisant intervenir des protéines, peptides ou amino-acides
G01N 33/82 - Analyse chimique de matériau biologique, p.ex. de sang ou d'urine; Test par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligands; Test immunologique faisant intervenir des vitamines
G01N 33/84 - Analyse chimique de matériau biologique, p.ex. de sang ou d'urine; Test par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligands; Test immunologique faisant intervenir des composés inorganiques ou le pH
The disclosure provides a recombinant cell capable of producing a steviol glycoside, wherein the cell comprises a nucleic acid coding for a variant of a parent polypeptide, wherein the variant has steviol glycoside transport mediating activity, wherein the variant comprises an amino acid sequence which, when aligned with the amino acid sequence of the parent polypeptide, comprises at least one modification of the amino acid residue corresponding to any of the amino acids in the amino acid sequence of the parent polypeptide, wherein the variant has an improved ability to produce rebaudioside M and optionally other steviol glycosides extracellularly if compared with the parent polytpeptide when measured under the same conditions.
C07K 14/39 - Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés provenant de champignons provenant de levures
C12P 19/56 - Préparation d'O-glucosides, p.ex. glucosides avec un atome d'oxygène du radical saccharide lié directement à un système cyclique condensé d'au moins trois carbocycles, p.ex. daunomycine, adriamycine
30 - Aliments de base, thé, café, pâtisseries et confiseries
31 - Produits agricoles; animaux vivants
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Flavourings for pet food, other than essential oils; animal feed flavorings other than essential oils Foodstuffs for pets; pet food containing ingredients and mixtures of ingredients with nutritional properties Chemical additives and nutritional additives for use in the manufacture of pet food; preparations made from microorganisms for the manufacture of pet food; prebiotics, probiotic and postbiotic preparations for use in the manufacture of pet food and the manufacture of dietary supplements for pets; biological preparations for the manufacture of pet food and the manufacture of nutritional supplements for pets; bacterial preparations for the manufacture of petfood and the manufacture of dietary supplements for pets; proteins for use as ingredients in the manufacture of petfood; enzymes for use in the manufacture of pet food; plant extracts for the petfood industry Dietetic and nutritional substances, supplements, additives and foodstuffs all for use as ingredient for pet food; animal feed additives for use as nutritional supplements; mineral food supplements for pets, vitamins for pets, amino acids for nutritional purposes for pets, fatty acids being nutritional supplements for pets, probiotic supplements for pets, prebiotics supplements for pets; non-medicated additives for animal feed for use as nutritional supplements; protein supplements for pets; food supplements and dietary supplements for pets; dietetic foods adapted for veterinary use; bacterial preparations for veterinary use; ferments with post-biotic, prebiotic or probiotic effects; preparations made from microorganisms for veterinary use; biological preparations for veterinary use; chemical preparations for veterinary use; chemical reagents for veterinary use; enzymes for use in pet food; dietary fiber for pet food
The present invention provides a feed composition comprising a) at least one organic acid and/or at least one salt thereof; and b) hypophosphorous acid and/or at least one salt thereof, and use thereof for improving growth performance and/or immunity, and/or reducing mortality of animals.
A23K 20/105 - Composés aliphatiques ou alicycliques
A23K 50/30 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les porcs
A23K 50/40 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les animaux carnivores, p.ex. pour les chats ou les chiens
A23K 50/75 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les oiseaux pour la volaille
A23K 50/80 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les animaux aquatiques, p.ex. pour les poissons, les crustacés ou les mollusques
38.
METHOD OF REDUCING EMULSION FORMATIONDURING FERMENTATION PROCESS
A method for the production of farnesene oil comprising fermenting yeast with feed stock in a fermentation vessel to produce a whole cell broth (WCB); and adding a surfactant to the fermentation vessel to reduce emulsification inside fermenter.
C07C 7/10 - Purification, séparation ou stabilisation d'hydrocarbures; Emploi d'additifs par extraction, c. à d. purification ou séparation d'hydrocarbures liquides à l'aide de liquides
39.
HUMAN MILK OLIGOSACCHARIDES IN CLEANSING COMPOSITION
The present invention relates to cleansing compositions comprising certain soaps and human milk oligosaccharides as well as to a method of increasing the foaming properties of cleansing compositions comprising at least one surfactant by incorporation of one or more human milk oligosaccharides into said cleansing composition.
The present invention provides composition comprising benzoic acid derivatives thereof in combination with yeast cell walls for improving growth performance of an animal.
A23K 10/16 - Ajout de micro-organismes ou de leurs produits d’extraction, p.ex. de protéines provenant d’organismes unicellulaires, à des compositions de produits alimentaires
42.
NOVEL USE OF AT LEAST A HUMAN MILK OLIGOSACCHARIDE
The present invention relates to compositions comprising at least one human milkoligosaccharide selected from the group consisting of 2′-fucosyllactose, difucosyllactose and/or lacto-N-tetraose as an anti-microbial agent against Cutibacterium acnes (C. acnes) as well as the use thereof in a regimen to prevent and/or treat acne comprising the steps of topically administering a composition comprising said human milk oligosaccharide(s) to the skin of a subject with acne/acne prone skin followed by topically administering a composition comprising one or more non-pathogenic live bacterial C. acnes strains.
A method of determining a quantitative composition ratio of a microbial strain mixture for use in a fermentation process. The method includes repeatedly performing method cycles, each method cycle comprising the steps of: selecting a set of plurality of microbial strain mixtures having different quantitative composition ratios; concurrently performing fermentation processes for each selected microbial strain mixture; determining, for each of the fermentation processes, at least one performance indicator of the microbial strain mixture; and providing the at least one performance indicator for each of the fermentation processes to a statistical model which is configured to optimize a predefined objective function, wherein the statistical model is configured to determine, based on said determined performance indicators, a subsequent set of plurality of microbial strain mixtures with different quantitative composition ratios for selection in a next cycle.
A23C 9/123 - Préparations à base de lait fermenté; Traitements utilisant des micro-organismes ou des enzymes ne comportant que des micro-organismes de la famille des lactobactériacées; Yoghourt
The invention relates to an extrusion apparatus for the continuous production of solid food supplements, feed additives or pharmaceutical preparations, which comprise nutritional or pharmaceutical actives homogeneously dispersed in a carrier material matrix. The invention also relates to a method for the production of such preparations by extrusion.
A23P 10/25 - Agglomération ou granulation par extrusion ou par compression, p.ex. par des petits trous, des tamis ou entre des surfaces
B29C 48/00 - Moulage par extrusion, c. à d. en exprimant la matière à mouler dans une matrice ou une filière qui lui donne la forme désirée; Appareils à cet effet
B29C 48/04 - Moulage par extrusion, c. à d. en exprimant la matière à mouler dans une matrice ou une filière qui lui donne la forme désirée; Appareils à cet effet caractérisées par la forme à l’extrusion de la matière extrudée en forme de particules
B29C 48/88 - Traitement thermique de l’écoulement de matière extrudée, p.ex. refroidissement
B29K 105/00 - Présentation, forme ou état de la matière moulée
The present invention relates to novel Lactobacillus strains with extended shelf- life properties, i.e., capability to extend the shelf-life at ambient temperature of a food product, such as e.g., a fermented milk product, when added to such products, without heavily diminishing the antimicrobial, antifungal and/or anti- yeast effect of said strains. The invention furthermore relates to a method of generating such novel strains, particularly generation via adaptive evolution.
C12N 15/01 - Préparation de mutants sans introduction de matériel génétique étranger; Procédés de criblage à cet effet
A23C 9/123 - Préparations à base de lait fermenté; Traitements utilisant des micro-organismes ou des enzymes ne comportant que des micro-organismes de la famille des lactobactériacées; Yoghourt
The present invention relates to novel Lactobacillus strains with extended shelf- life properties, i.e., capability to extend the shelf-life at ambient temperature of a food product, such as e.g., a fermented milk product, when added to such products, without heavily diminishing the antimicrobial, antifungal and/or anti- yeast effect of said strains. According to another aspect, the present invention relates to an antimicrobial, antifungal or anti-yeast composition. According to yet another aspect, the present invention relates to a food product. According to another aspect, the invention relates to a process for manufacturing a food product. According to another aspect, the present invention relates to the use of a Lactobacillus strain for providing an antifungal, antimicrobial and/or anti-yeast effect, for example in a fermented milk product.
C12N 15/01 - Préparation de mutants sans introduction de matériel génétique étranger; Procédés de criblage à cet effet
A23C 9/123 - Préparations à base de lait fermenté; Traitements utilisant des micro-organismes ou des enzymes ne comportant que des micro-organismes de la famille des lactobactériacées; Yoghourt
A23C 13/16 - Préparations à base de crème contenant des micro-organismes, des enzymes, ou des antibiotiques, ou traités à l'aide de ceux-ci; Crème aigre
A23C 19/06 - Traitement du caillé après la séparation du petit-lait; Produits ainsi obtenus
Disclosed herein are devices and methods for processing biologic tissues, such as adipose tissue or whole blood, via centrifugation, An annular cavity is present, typically at the widest interior point of a rotatable chamber. The device is operable such that a sample of biologic tissue present in the rotatable chamber can be stratified into at least two constituent layers as a function of the differing specific gravities of the constituents and at least a portion of one of the constituent layers captured in the annular cavity.
B04B 1/02 - Centrifugeurs à tambours rotatifs à parois pleines pour la séparation de mélanges essentiellement liquides contenant ou non des particules solides sans cloisons intérieures
B04B 1/14 - Centrifugeurs à tambours rotatifs à parois pleines pour la séparation de mélanges essentiellement liquides contenant ou non des particules solides à orifices d'évacuation dans le plan du plus grand diamètre du tambour à évacuation cyclique
B04B 3/00 - Centrifugeurs à tambours rotatifs dans lesquels les particules ou les corps solides sont séparés par la force centrifuge et simultanément par tamisage ou filtration
50.
SYNTHETIC BIOPOLYMER SOLUTIONS WITH INCREASED LOWER CRITICAL SOLUTION TEMPERATURES
Synthetic biopolymers are disclosed, which can be engineered in terms of both their amino acid sequences and post-synthesis treatments to which they are subjected, to achieve desired gelation characteristics, particularly upon or after being exposed to physiological temperature (e.g., 37°C), including their use in an aqueous solution including a critical solution temperature agent that increases a baseline lower critical solution temperature of synthetic biopolymer solution, for example to raise it above physiological temperature for application and, upon diffusion of the agent after application, the lower critical solution temperature drops and the synthetic biopolymer gels in the physiological environment. Examples of synthetic biopolymers are synthetic elastin-like polypeptides (ELPs) having polypeptide sequences with functional oligopeptide blocks that may include one or more hydrophobic blocks, one or more aggregation-enhancing blocks, and one or more β-sheet formation-inducing blocks.
C07K 14/78 - Peptides du tissu connectif, p.ex. collagène, élastine, laminine, fibronectine, vitronectine, globuline insoluble à froid (CIG)
A61K 47/00 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p.ex. les supports ou les additifs inertes; Agents de ciblage ou de modification chimiquement liés à l’ingrédient actif
A61K 47/20 - Composés organiques, p.ex. hydrocarbures naturels ou synthétiques, polyoléfines, huile minérale, gelée de pétrole ou ozocérite contenant du soufre, p.ex. sulfoxyde de diméthyle [DMSO], docusate, laurylsulfate de sodium ou acides aminosulfoniques
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
05 - Produits pharmaceutiques, vétérinaires et hygièniques
30 - Aliments de base, thé, café, pâtisseries et confiseries
31 - Produits agricoles; animaux vivants
Produits et services
Chemical additives and nutritional additives for use in the manufacture of pet food; preparations made from microorganisms for the manufacture of pet food; prebiotics, probiotic and postbiotic preparations for use in the manufacture of pet food and the manufacture of dietary supplements for pets; biological preparations for the manufacture of pet food and the manufacture of nutritional supplements for pets; bacterial preparations for the manufacture of petfood and the manufacture of dietary supplements for pets; proteins for use as ingredients in the manufacture of petfood; enzymes for use in the manufacture of pet food; plant extracts for the petfood industry. Dietetic and nutritional substances, supplements, additives and foodstuffs, all for use as ingredient for pet food; animal feed additives for use as nutritional supplements; mineral food supplements for pets, vitamins for pets, amino acids for nutritional purposes for pets, fatty acids being nutritional supplements for pets, probiotic supplements for pets, prebiotics supplements for pets; non-medicated additives for animal feed for use as nutritional supplements; protein supplements for pets; food supplements and dietary supplements for pets; dietetic foods adapted for veterinary use; bacterial preparations for veterinary use; ferments with post-biotic, prebiotic or probiotic effects; preparations made from microorganisms for veterinary use; biological preparations for veterinary use; chemical preparations for veterinary use; chemical reagents for veterinary use; enzymes for use in pet food; dietary fiber for pet food. Flavourings for pet food, other than essential oils; animal feed flavourings other than essential oils. Foodstuffs for pets; pet food containing ingredients and mixtures of ingredients with nutritional properties.
The present invention relates to a new formulation, which is a gelled confection, which comprises a high amount (concentration) of at least one PUFA. In an embodiment, a gelled confection comprises encapsulated particles comprising a coacervate shell encapsulating at least one PUFA, at least one gelling substance, and water, wherein the content of the at least one PUFA is at least 10mg/g of the gelled confection.
A23L 29/281 - Protéines, p.ex. gélatine ou collagène
A23G 3/36 - Sucreries, confiseries ou massepain; Procédés pour leur fabrication caractérisés par la composition
A23G 3/40 - Sucreries, confiseries ou massepain; Procédés pour leur fabrication caractérisés par la composition caractérisés par les matières grasses utilisées
The present invention relates to sulfate-free cleansing compositions comprising at least one zwitterionic surfactant and at least one human milk oligosaccharide as well as to a method of increasing the foaming properties of cleansing compositions comprising at least one surfactant by incorporation of one or more human milk oligosaccharides into said cleansing composition.
The present disclosure relates to a recombinant cell capable of producing one or more mogroside precursors and/or one or more mogrosides in a culture medium, wherein the cell has been modified to result in a deficiency of a polypeptide capable of deglycosylating a mogroside product. Methods for producing one or more mogroside precursors and/or one or more mogrosides in a culture medium using such recombinant cell led to improved production of mogrosides.
03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
Produits et services
Cosmetics and cosmetic preparations, also for make-up, beauty, eye care, scalp care, foot care, lip care, hair care, face care, body care, skin care and hand care; Cosmetics, make-up, eye care products, hair care products, scalp care products, foot care products, lip care products, face care products, body care products, skin care products and hand care products for the prevention of sunburn; Sun-tan and sun-screening preparations; sun care preparations; compounds for skin care after exposure to the sun's rays; Preparations and substances for the conditioning, cleaning, care, treatment and beautification and appearance of the eye, skin, body, face, scalp, hair, foot, lips and hand (non-medicated)
The present invention relates to a compound thickener comprising rhamsan gum and gellan gum. In the compound thickener, rhamsan gum accounts for 50%-95% of the total weight of rhamsan gum and gellan gum. The combination of rhamsan gum and gellan gum in the compound thickener produces a synergistic effect, and its viscosity is remarkably improved. The compound thickener can be applied to products such as foods, beverages, pharmaceutical products, and personal care products, and when the compound thickener is applied as a gelling agent in soft capsule shells, the shell strength and the shell elasticity are better.
Infant formulae with a very low level of arsenic are obtained by selecting the components of the infant formula very carefully. For manufacturing infant formulae that comprise less than 95 parts per billion (ppb) of arsenic, it is preferred to use human milk oligosaccharides (HMOs) that have been isolated from a fermentation brth without using activated carbon in the last purification step. The preferred HMO is 2′-O-fucosyllactose.
A23L 33/125 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
C07C 37/02 - Préparation de composés comportant des groupes hydroxyle ou O-métal liés à un atome de carbone d'un cycle aromatique à six chaînons par remplacement des groupes fonctionnels liés à un cycle aromatique à six chaînons par des groupes hydroxyle, p.ex. par hydrolyse par substitution d'atomes d'halogène
C07C 39/07 - Phénols alkylés ne contenant comme groupes alkyles que des groupes méthyle, p.ex. crésols, xylénols
C07C 37/055 - Préparation de composés comportant des groupes hydroxyle ou O-métal liés à un atome de carbone d'un cycle aromatique à six chaînons par remplacement des groupes fonctionnels liés à un cycle aromatique à six chaînons par des groupes hydroxyle, p.ex. par hydrolyse par substitution d'un groupe lié au cycle par un oxygène, p.ex. d'un groupe éther
C07C 37/64 - Préparation de composés O-métal dont le groupe O-métal est lié à un atome de carbone appartenant à un cycle aromatique à six chaînons
59.
PROCESS FOR DEGUMMING FEEDSTOCK COMPRISING BRASSICA CARINATA OIL
03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
Produits et services
Cosmetics and cosmetic preparations, also for make-up, beauty, eye care, scalp care, foot care, lip care, hair care, face care, body care, skin care and hand care; cosmetics, make-up, eye care products, hair care products, scalp care products, foot care products, lip care products, face care products, body care products, skin care products and hand care products for the prevention of sunburn; sun-tan and sun-screening preparations; sun care preparations; compounds for skin care after exposure to the sun's rays; preparations and substances for the conditioning, cleaning, care, treatment and beautification and appearance of the eye, skin, body, face, scalp, hair, foot, lips and hand (non-medicated).
Compositions are formed of a compressed mixture which includes a powderous formulation of a carrier and 3-nitrooxypropanol or derivatives thereof as an active ingredient, and a gluten. The composition remains intact in water after 24 hours.
A process for the preparation of a fermented milk product comprising the steps of: —providing a milk base comprising glucose and fructose; and —fermenting the milk base in the presence of a lactic acid bacterial strain and a glucose-fructose oxidoreductase enzyme.
A23C 9/12 - Préparations à base de lait fermenté; Traitements utilisant des micro-organismes ou des enzymes
A23C 9/123 - Préparations à base de lait fermenté; Traitements utilisant des micro-organismes ou des enzymes ne comportant que des micro-organismes de la famille des lactobactériacées; Yoghourt
63.
GLUCOAMYLASE AS BINDING AGENT FOR NON-ANIMAL PROTEIN FOOD PRODUCTS
The present invention relates to the field of food. Herein disclosed is a method for preparing a non-animal protein food product or a cultured meat food product comprising adding a thermolabile glucoamylase protein preparation to an ingredient used in the preparation of said food product and processing the obtained glucoamylase protein preparation and ingredient composition into a non-animal protein food product or a cultured meat food product.
A23J 3/22 - Traitement des protéines pour l'alimentation par texturation
A23L 29/20 - Aliments ou produits alimentaires contenant des additifs; Leur préparation ou leur traitement contenant des agents gélifiants ou épaississants
A23J 3/20 - Protéines à partir de micro-organismes ou à partir d'algues unicellulaires
A23L 29/206 - Aliments ou produits alimentaires contenant des additifs; Leur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine végétale
A23L 29/269 - Aliments ou produits alimentaires contenant des additifs; Leur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine microbienne, p.ex. xanthane ou dextrane
A23L 29/281 - Protéines, p.ex. gélatine ou collagène
The present invention relates to a cereal flour-based dough comprising at least 50 wt. % cereal flour, based on the dry weight of the cereal flour-based dough, and rapeseed protein, wherein said rapeseed protein is present in an amount between 0.01 and 15 wt. %, based on the weight of the cereal flour in the cereal flour-based dough, wherein the cereal flour has a gluten content of 5-20 wt. %.
A61K 31/702 - Oligosaccharides, c. à. d. ayant trois à cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiques
A23K 20/00 - PRODUITS ALIMENTAIRES SPÉCIALEMENT ADAPTÉS AUX ANIMAUX; PROCÉDÉS SPÉCIALEMENT ADAPTÉS À LEUR FABRICATION Éléments nutritifs accessoires pour produits alimentaires pour animaux
A23L 33/125 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
A61P 11/00 - Médicaments pour le traitement des troubles du système respiratoire
This invention relates to a method of producing mixtures of various human milk oligosaccharides (HMOs) with unique HMO blend profiles, consisting predominantly of LNFP-I and LNT and of other HMOs in less significant amounts. The less abundant HMOs might be 2′-FL, LNT-II or DFL. The strategies for achieving specific HMO blends include strain engineering and fermentation methods.
C12N 15/52 - Gènes codant pour des enzymes ou des proenzymes
C12P 19/18 - Préparation de composés contenant des radicaux saccharide préparés par action d'une transférase glycosylique, p.ex. alpha-, bêta- ou gamma-cyclodextrines
A composition comprising or consisting of: - a first enzymatic component, comprising or consisting of a glutamine-specific protease and/or prolyl- specific protease, preferably a glutamine-specific endoprotease and/or prolyl-specific endoprotease, most preferably a prolyl-specific endoprotease; and - a second enzymatic component, comprising or consisting of a cellulolytic enzyme, preferably cellulase, wherein preferably the second enzymatic component is derived from and/or produced by a Trichoderma reesei.
A23L 5/20 - Préparation ou traitement des aliments ou produits alimentaires en général; Aliments ou produits alimentaires ainsi obtenus; Leurs matériaux Élimination de constituants indésirables, p.ex. désodorisation ou détoxication
C12N 9/62 - Protéinases provenant de champignons d'Aspergillus
A23J 3/34 - Traitement des protéines pour l'alimentation par hydrolyse utilisant des agents chimiques utilisant des enzymes
A23L 2/84 - Clarification ou affinage des boissons non alcoolisées; Elimination des matières non désirées utilisant des micro-organismes ou un matériau biologique, p.ex. enzymes
C12C 5/00 - Autres matières premières pour la préparation de la bière
C12N 9/96 - Stabilisation d'une enzyme par formation d'un adduct ou d'une composition; Formation de conjugaisons d'enzymes
C12P 1/06 - Préparation de composés ou de compositions, non prévue dans les groupes , utilisant des micro-organismes ou des enzymes; Procédés généraux de préparation de composés ou de compositions utilisant des micro-organismes ou des enzymes utilisant des actinomycètes
A composition comprising or consisting of: - an enzymatic component, comprising or consisting of an endoprotease, preferably a prolyl-specific endoprotease; and - a solution stabilizer and/or an osmolyte; and - optionally a solvent.
C12N 9/62 - Protéinases provenant de champignons d'Aspergillus
C12N 9/96 - Stabilisation d'une enzyme par formation d'un adduct ou d'une composition; Formation de conjugaisons d'enzymes
C12P 21/06 - Préparation de peptides ou de protéines préparés par hydrolyse d'une liaison peptidique, p.ex. hydrolysats
A23J 3/34 - Traitement des protéines pour l'alimentation par hydrolyse utilisant des agents chimiques utilisant des enzymes
A23L 2/84 - Clarification ou affinage des boissons non alcoolisées; Elimination des matières non désirées utilisant des micro-organismes ou un matériau biologique, p.ex. enzymes
The invention relates to the field of fermentation technology. The invention specifically relates to genes that are useful for protecting bacterial strains from phage infections, and to bacterial strains comprising such genes. Such strains can be used in methods to produce a fermented food product such as a fermented milk product. The invention also relates to food products produced using such strain or composition.
C07K 14/335 - Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés provenant de bactéries provenant de Lactobacillus (G)
C12N 15/74 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes procaryotes autres que E. coli, p.ex. Lactobacillus, Micromonospora
A23C 9/12 - Préparations à base de lait fermenté; Traitements utilisant des micro-organismes ou des enzymes
A23C 9/123 - Préparations à base de lait fermenté; Traitements utilisant des micro-organismes ou des enzymes ne comportant que des micro-organismes de la famille des lactobactériacées; Yoghourt
C07K 14/195 - Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés provenant de bactéries
C07K 14/315 - Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés provenant de bactéries provenant de Streptococcus (G), p.ex. Enterocoques
A feed control system and related methods for a heterologous product, such as a human milk oligosaccharide, fermentation system are disclosed. The feed control system comprises a feed controller. The feed controller comprises a processor and an interface. The processor is configured to obtain a biomass content in a fermentation broth. The processor is configured to determine a carbon input parameter based on the biomass content. The processor is configured to control a carbon input to the fermentation broth according to the carbon input parameter.
C12M 1/36 - Appareillage pour l'enzymologie ou la microbiologie comportant une commande sensible au temps ou aux conditions du milieu, p.ex. fermenteurs commandés automatiquement
C12M 1/34 - Mesure ou test par des moyens de mesure ou de détection des conditions du milieu, p.ex. par des compteurs de colonies
Methods to improve retention of propanediol mononitrate and derivatives thereof in a powderous formulation comprising the propane diol mononitrate and silica include forming a uniform mixture of (i) the powderous formulation and (ii) at least one inorganic carbonate in an amount to achieve a weight ratio of the at least one inorganic carbonate to the powderous formulation of at least 1:1. The at least one inorganic carbonate is present in an amount such that a weight ratio (w/w) in the uniform mixture of the at least one inorganic carbonate to the compound of formula (1) is at least 50:1 sufficient to achieve storage stability of the uniform mixture such that retention of the compound of formula (I) is improved by at least 10% when stored in a closed container for 1 month at 25° C. and 50% relative humidity as compared to a mixture which does not include the at least one inorganic carbonate.
The present disclosure relates to a method for the production of a human milk oligosaccharide (HMO) blend with LNFP-I and 2′-FL as the predominant HMO's, the method comprising the steps of providing a genetically engineered cell, which comprises a heterologous β-1,3-N-acetyl-glucosaminyltransferase protein, a heterologous β-1,3-galactosyltransferase protein, a heterologous α-1,2-fucosyltransferase protein, and expresses functionally the colanic acid gene cluster, comprises a native or heterologous regulatory or episomal element for controlling the expression of the proteins and optionally express a heterologous sugar transporter, and culturing the cell in a suitable cell culture medium to express said proteins and to produce an HMO blend.
The present invention relates to a process for the production of an intermediate, which is useful in organic synthesis, especially in the production of astaxanthin.
C07C 403/08 - Dérivés du cyclohexane ou d'un cyclohexène, comportant une chaîne latérale avec une partie non saturée d'au moins quatre atomes de carbone en ligne, ladite partie étant directement attachée aux cycles cyclohexane ou cyclohexène, p.ex. vitamine A, bêt ayant des chaînes latérales substituées par des atomes d'oxygène liés par des liaisons simples par des groupes hydroxy
C07C 403/24 - Dérivés du cyclohexane ou d'un cyclohexène, comportant une chaîne latérale avec une partie non saturée d'au moins quatre atomes de carbone en ligne, ladite partie étant directement attachée aux cycles cyclohexane ou cyclohexène, p.ex. vitamine A, bêt ayant des chaînes latérales substituées par des cycles non aromatiques à six chaînons, p.ex. bêta-carotène
C07D 317/46 - Composés hétérocycliques contenant des cycles à cinq chaînons comportant deux atomes d'oxygène comme uniques hétéro-atomes du cycle comportant les hétéro-atomes en positions 1, 3 condensés en ortho ou en péri avec des carbocycles ou avec des systèmes carbocycliques condensés avec un cycle à six chaînons
The present invention relates to a process for fermenting Yarrowia in a bioreactor, comprising cultivating Yarrowia in a medium, and adding a feed comprising formic acid and a sugar to the medium in a molar ratio of formic acid to sugar of 1 to 13 mol formic acid/mol monosaccharide.
C12M 1/36 - Appareillage pour l'enzymologie ou la microbiologie comportant une commande sensible au temps ou aux conditions du milieu, p.ex. fermenteurs commandés automatiquement
C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
The present invention relates to cosmetic compositions containing an alkandiol and one or more cosmetic oils, characterized in that at least one of the cosmetic oils is isoamyl caprylate caprate. Said compositions exhibit an improved water repellency (lotus effect) and sensory attributes.
A61K 8/49 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant des composés hétérocycliques
A61Q 17/04 - Préparations topiques pour faire écran au soleil ou aux radiations; Préparations topiques pour bronzer
A61Q 19/00 - Préparations pour les soins de la peau
The present invention relates to sunscreen compositions containing bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT) and one or more cosmetic oils, characterized in that at least one of the cosmetic oils is isoamyl caprylate caprate. Said compositions exhibit an improved water repellency (lotus effect) and sensory attributes.
A61K 8/49 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant des composés hétérocycliques
A61Q 17/04 - Préparations topiques pour faire écran au soleil ou aux radiations; Préparations topiques pour bronzer
The present invention relates to a new formulation comprising a high amount of at least one cannabinoid, wherein the cannabinoid is in a non-crystalline form.
The present invention relates to the manufacture of gamma, delta-unsaturated ketones from tertiary vinyl carbinols and vinylic ethers or ketals using an organic tertiary or quaternary ammonium salt as catalyst.
C07C 45/51 - Préparation de composés comportant des groupes C=O liés uniquement à des atomes de carbone ou d'hydrogène; Préparation des chélates de ces composés par pyrolyse, réarrangement ou décomposition
B01J 31/02 - Catalyseurs contenant des hydrures, des complexes de coordination ou des composés organiques contenant des composés organiques ou des hydrures métalliques
The present invention relates to a new formulation comprising a high amount of at least one cannabinoid, wherein the cannabinoid is in a non-crystalline form.
The invention provides a process for the production of a fermented milk product, preferably a yogurt, comprising the steps of: (a) fermenting the milk-base with one or more lactic acid bacterial strains, a coagulant and a stabilizer to generate a fermented milk product; and (b) heat treating the fermented milk product at a temperature of at least 70°C for a period of at least 5 seconds to generate a heat-treated fermented milk product. Preferably the heat-treated fermented milk product is subsequently stored in a step (c) at a temperature in the range from equal to or more than 10°C to equal to or less than 40°C.
A23C 9/12 - Préparations à base de lait fermenté; Traitements utilisant des micro-organismes ou des enzymes
A23C 9/127 - Préparations à base de lait fermenté; Traitements utilisant des micro-organismes ou des enzymes comportant des micro-organismes de la famille des lactobactériacées et d'autres micro-organismes ou des enzymes, p.ex. kéfir, koumiss
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
Produits et services
Hydrocolloids, gelling agents, thickening agents, stabilizers, emulsifiers, binding agents, gums, modified starches, pectins and fibers for use in the manufacture of food and beverage products, pharmaceuticals, personal care products and cosmetics.
The present invention relates to a novel palladium hydrogenation catalyst and its use for the partial (selective) hydrogenation of a carbon-carbon triple bond.
C07C 5/09 - Préparation d'hydrocarbures à partir d'hydrocarbures contenant le même nombre d'atomes de carbone par hydrogénation de liaisons triples carbone-carbone en liaisons doubles carbone-carbone
C07C 29/17 - Préparation de composés comportant des groupes hydroxyle ou O-métal liés à un atome de carbone ne faisant pas partie d'un cycle aromatique à six chaînons par hydrogénation de liaisons doubles ou triples carbone-carbone
C07C 67/283 - Préparation d'esters d'acides carboxyliques par modification de la partie hydroxyle de l'ester sans introduction d'un groupe ester par hydrogénation de liaisons non saturées carbone-carbone
C07C 403/08 - Dérivés du cyclohexane ou d'un cyclohexène, comportant une chaîne latérale avec une partie non saturée d'au moins quatre atomes de carbone en ligne, ladite partie étant directement attachée aux cycles cyclohexane ou cyclohexène, p.ex. vitamine A, bêt ayant des chaînes latérales substituées par des atomes d'oxygène liés par des liaisons simples par des groupes hydroxy
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
probiotic preparations for use in the dietary supplement industry; prebiotic preparations for use in the dietary supplement industry; postbiotic preparations for use in the dietary supplement industry; probiotics for use in the manufacture of nutraceuticals; prebiotics for use in the manufacture of nutraceuticals; postbiotics for use in the manufacture of nutraceuticals; probiotic and prebiotic bacteria for the food industry; probiotic or prebiotic bacterial formulations (other than for medical use); cultures of microorganisms other than for medical or veterinary use; bacteria, molecules and microorganisms for addition to dietary supplements and food products dietary supplements; probiotic preparations for medical purposes; prebiotic supplements; probiotic supplements; postbiotic supplements; microbiome preparations for dietary purposes
84.
SYNTHESIS OF DIMETHYLPHENOL OR TRIMETHYLPHENOL FROM 2,5-DIMETHYLFURAN USING A PLATINUM CATALYST
The present invention relates to the manufacturing of dimethylphenols, particularly 2,5-dimethylphenol, respectively trimethylphenols, particularly 2,3,6-trimethylphenol, from 2,5-dimethylfuran and acetylene, respectively propyne, particularly in MAP gas, in the presence of a platinum catalyst. This invention offers a sustainable synthesis of β-tocopherols, respectively α-tocopherols.
C07C 37/14 - Préparation de composés comportant des groupes hydroxyle ou O-métal liés à un atome de carbone d'un cycle aromatique à six chaînons par des réactions augmentant le nombre d'atomes de carbone par des réactions d'addition, c. à d. par des réactions faisant intervenir au moins une liaison carbone-carbone non saturée
C07C 39/07 - Phénols alkylés ne contenant comme groupes alkyles que des groupes méthyle, p.ex. crésols, xylénols
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
05 - Produits pharmaceutiques, vétérinaires et hygièniques
29 - Viande, produits laitiers et aliments préparés ou conservés
30 - Aliments de base, thé, café, pâtisseries et confiseries
32 - Bières; boissons non alcoolisées
Produits et services
Chemical and biochemical products for industrial use for the production of food, beverages and dietary products; cultures and fermented preparations of microorganisms for industrial use for the production of food, beverages and dietary products; microbiologically produced, namely, algal biomass, algal oil, plant oil, algal powder, plant powder, and algae containing lipids for use in the manufacture of nutritional and dietary supplements and additives, vitamins, and nutritional supplement ingredients; fatty acids; omega-3 fatty acids. Food supplements; dietary supplements; dietetic substances for medical use; ingredients for (dietetic) foods for medical use, namely food additives for use as nutritional supplements; Nutritional drinks namely powdered nutritional supplement drink mix; food for babies; infant formula; milk for babies; food for the sick, for medical use; vitamins and vitamin preparations; medicinal oil; vitamin oil for human consumption; confectionary for medicinal purposes. Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits and vegetables; jellies, jams, compotes; eggs, milk; milk products, namely, milk based beverages, non-alcoholic specialty non-carbonated milk based fruit flavored drinks, non-alcoholic milk based beverages, non-alcoholic yoghurt based beverages, milk powder, chocolate milk, spreadable edible fat, and cheese; edible oils and fats; butter; peanut butter; algae oil for food; vegetable oil and cooking oil; soups, soup concentrates; dairy products excluding ice cream, ice milk and frozen yogurt; dairy-based beverages; soy-based food beverage used as a milk substitute; potato chips. Coffee, tea, cocoa, artificial coffee; tapioca, sago; flour; preparations made from cereals, namely, mixes for making bakery goods, namely pancake mix, cake mix, muffin mix, cookie mix, and breakfast cereals, processed cereals, muesli, cereal-based snack food, ready-to-eat cereal derived food bars; bread; pastry; confectionery, namely, candy and chocolate candy; ices; sugar; honey, treacle; baking powder; chocolate; cereal bars, biscuits, cookies and cake; rice; rice products, namely, puffed rice, rice bread, and rice cakes; pasta; muesli; sauces used as a condiment; spices; seasonings for food; salad dressings; milk products namely, ice milk; snacks not included in other classes, namely rice-based snack foods, chocolate snacks, muesli snacks; ready-to-eat meals as far as included in this class, namely, frozen, prepared and packaged meals consisting primarily of pasta or rice. Non-alcoholic carbonated beverages; fruit drinks and fruit juices; syrups for making beverages; preparations for making beverages, namely, fruit drinks, fruit juices and soft drinks; non-alcoholic sport drinks; non-alcoholic energy-drinks; soy-based beverages not being milk substitutes; nutritionally fortified beverages.
The present invention relates to a method for improving enzyme kinetics of a fumonisin esterase, an improved fumonisin esterase, use thereof, a composition comprising the fumonisin esterase, and a method for modifying a fumonisin.
The present invention relates to a process of manufacturing 2,3,5-tri- methylhydroquinone from a mixture of mesitol and 2,3,6-trimethylphenol (=2,3,6- TMP). This process offers a highly interesting and commercial interesting way of producing α-tocopherol.
C07C 37/07 - Préparation de composés comportant des groupes hydroxyle ou O-métal liés à un atome de carbone d'un cycle aromatique à six chaînons par conversion de cycles non aromatiques à six chaînons ou de tels cycles formés in situ, en cycles aromatiques à six chaînons, p.ex. par déshydrogénation avec réduction simultanée du groupe C=O de ce cycle
C07C 39/08 - Dihydroxybenzènes; Leurs dérivés alkylés
C07C 37/16 - Préparation de composés comportant des groupes hydroxyle ou O-métal liés à un atome de carbone d'un cycle aromatique à six chaînons par des réactions augmentant le nombre d'atomes de carbone par condensation impliquant des groupes hydroxyle de phénols ou d'alcools, ou leurs groupes éther ou ester minéral
C07C 37/14 - Préparation de composés comportant des groupes hydroxyle ou O-métal liés à un atome de carbone d'un cycle aromatique à six chaînons par des réactions augmentant le nombre d'atomes de carbone par des réactions d'addition, c. à d. par des réactions faisant intervenir au moins une liaison carbone-carbone non saturée
C07C 39/07 - Phénols alkylés ne contenant comme groupes alkyles que des groupes méthyle, p.ex. crésols, xylénols
C07C 45/64 - Préparation de composés comportant des groupes C=O liés uniquement à des atomes de carbone ou d'hydrogène; Préparation des chélates de ces composés par des réactions ne créant pas de groupe C=O par introduction de groupes fonctionnels contenant de l'oxygène lié uniquement par liaison simple
C07C 49/713 - Composés non saturés comportant un groupe cétone faisant partie d'un cycle contenant des groupes hydroxyle un groupe cétone faisant partie d'un cycle à six chaînons
C07C 46/06 - Préparation de quinones par oxydation avec formation de structures quinoïdes d'au moins un groupe hydroxyle d'un cycle aromatique à six chaînons
C07C 50/02 - Quinones à structure quinoïde monocyclique
C07C 409/14 - Composés peroxy le groupe —O—O— étant lié à un atome de carbone, qui n'est pas substitué de plus par des atomes d'oxygène, et à un atome d'hydrogène, c. à d. hydroperoxydes l'atome de carbone appartenant à un cycle autre qu'un cycle aromatique à six chaînons
88.
SYNTHESIS OF 2,3,6-TRIMETHYLPHENOL FROM 5-METHYL-1,3-DIHYDROISOBENZOFURAN-4-OL OR ITS ESTER COMPRISING A RING OPENING AND A REDUCING STEP
The present invention relates to the synthesis of 2,3,6-trimethylphenol from 5-methyl-1,3-dihydroisobenzofuran-4-ol or its ester comprising a ring opening step and a reducing step.
C07C 37/055 - Préparation de composés comportant des groupes hydroxyle ou O-métal liés à un atome de carbone d'un cycle aromatique à six chaînons par remplacement des groupes fonctionnels liés à un cycle aromatique à six chaînons par des groupes hydroxyle, p.ex. par hydrolyse par substitution d'un groupe lié au cycle par un oxygène, p.ex. d'un groupe éther
C07C 39/07 - Phénols alkylés ne contenant comme groupes alkyles que des groupes méthyle, p.ex. crésols, xylénols
C07C 67/24 - Préparation d'esters d'acides carboxyliques par réaction d'acides carboxyliques ou de leurs dérivés avec une liaison éther carbone-oxygène, p.ex. acétal, tétrahydrofuranne
C07C 69/18 - Esters d'acide acétique de composés trihydroxylés
89.
5-METHYL-1,3-DIHYDROISOBENZOFURAN-4-OL PREPARED FROM 5-METHYLFURFURYL ALCOHOL AND PROPARGYL ALCOHOL
The present invention relates to the formation of 5-methyl-1,3- dihydroisobenzofuran-4-ol. It can be produced in a one-pot procedure from 5- methylfurfuryl alcohol and propargyl alcohol in the presence of ether or aromatic hydrocarbon and a platinum catalyst.
The present invention relates to a composition comprising rapeseed protein, a vegetable fat having a solid fat content of 20-90% (w/w) at 5° C., sucrose and water, wherein the amount of rapeseed protein is from 0.1-10% (w/w), wherein the amount of vegetable fat is from 1-40% (w/w) and wherein the amount of sucrose is from 1-25% (w/w).
A23G 9/38 - Desserts glacés, p.ex. confiseries glacées, glaces; Mélanges correspondants caractérisés par la composition contenant des peptides ou des protéines
A23D 7/005 - Compositions à base d'huiles ou de graisses comestibles, contenant une phase aqueuse, p.ex. margarines caractérisées par des ingrédients autres que des triglycérides d'acides gras
A23G 9/34 - Desserts glacés, p.ex. confiseries glacées, glaces; Mélanges correspondants caractérisés par la composition caractérisés par les hydrates de carbone utilisés, p.ex. des polysaccharides
Methods of feeding animals are disclosed wherein providing feed additives are provided that modulate the gut microbiome to improve the health, nutrition, and growth performance. Methods of modulating the microbial species present in the gastrointestinal tract of an animal are also disclosed. Such modulation includes, for example, modulating the level or function of microbial species.
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
probiotic preparations for use in the dietary supplement industry; prebiotic preparations for use in the dietary supplement industry; postbiotic preparations for use in the dietary supplement industry; probiotics for use in the manufacture of nutraceuticals; prebiotics for use in the manufacture of nutraceuticals; postbiotics for use in the manufacture of nutraceuticals; probiotic and prebiotic bacteria for the food industry; probiotic or prebiotic bacterial formulations (other than for medical use); cultures of microorganisms other than for medical or veterinary use; bacteria, molecules and microorganisms for addition to dietary supplements and food products. dietary supplements; probiotic preparations for medical purposes; prebiotic supplements; probiotic supplements; postbiotic supplements; microbiome preparations for dietary purposes.
93.
SEPARATION OF HUMAN MILK OLIGOSACCHARIDES FROM A FERMENTATION BROTH
The invention relates to a method for recovery and purification of a neutral or sialylated human milk oligosaccharide (HMO) from a fermentation broth, comprising the steps of separating the fermentation broth to form a separated HMO-containing stream and a biomass waste stream, purifying the HMO-containing stream by nanofiltration, purifying the HMO-containing stream with an acidic cation exchange resin, concentrating the purified HMO-containing stream, and drying the purified HMO-containing stream to obtain a solidified neutral or sialylated HMO. Moreover, the invention also concerns a neutral or sialylated human milk oligosaccharide obtained by the inventive method, as well as its use in food, feed, and medical application.
C07H 3/06 - Oligosaccharides, c. à d. saccharides comportant de trois à cinq radicaux saccharide liés entre eux par des liaisons glucosidiques
B01J 47/014 - Procédés d'échange d'ions en général; Appareillage à cet effet dans lesquels les propriétés d’adsorption de l’échangeur d’ions sont utilisées, p.ex. récupération de protéines ou de composés macromoléculaires
C07H 1/08 - Séparation; Purification à partir de produits naturels
94.
PRODUCT SPECIFIC TRANSPORTER FOR IN VIVO SYNTHESIS OF HUMAN MILK OLIGOSACCHARIDES
The present disclosure relates to a genetically engineered cell capable of producing a desired HMO, wherein said cell expresses a transporter protein capable of exporting of the desired HMO from said cell. The application also relates to a method of producing the desired HMO using the genetically engineered cell. Preferably, the desired HMO has an LNT-II backbone, such as for example LNT or LNnT.
C12N 15/63 - Introduction de matériel génétique étranger utilisant des vecteurs; Vecteurs; Utilisation d'hôtes pour ceux-ci; Régulation de l'expression
C12P 19/04 - Polysaccharides, c. à d. composés contenant plus de cinq radicaux saccharide reliés entre eux par des liaisons glucosidiques
95.
SEPARATION OF HUMAN MILK OLIGOSACCHARIDES FROM A FERMENTATION BROTH
The invention relates to a method for recovery and purification of a neutral or sialylated human milk oligosaccharide (HMO) from a fermentation broth, comprising the steps of separating the fermentation broth to form a separated HMO-containing stream and a biomass waste stream, purifying the HMO-containing stream by ultrafiltration using an ultrafiltration membrane having a MWCO of 500 Da to 5 kDa, purifying the HMO-containing stream by nanofiltration, concentrating the purified HMO-containing stream, and drying the purified HMO-containing stream to obtain a solidified neutral or sialylated HMO. Moreover, the invention also concerns a neutral or sialylated human milk oligosaccharide obtained by the inventive method, as well as its use in food, feed, and medical application.
The present invention relates to a method for modulating behavior of an animal, improving animal welfare, and for increasing production of gamma-aminobutyric acid, kynurenine and/or serotonin improving animal performance, using an oligosaccharide preparation.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
31 - Produits agricoles; animaux vivants
Produits et services
Dietary supplements for animals; feed additives for animals; medicated supplements for foodstuffs for animals; feed supplements for veterinary use; feeding stimulants for animals; medicated animal feed; medicated additives for animal foods; probiotic supplements for animals; enzymes for veterinary purposes; enzyme dietary supplements for animals; amino acids for veterinary purposes; protein supplements for animals; bacterial preparations for veterinary purposes; herbal detoxification agents for animals; mineral dietary supplements for animals; nutritional supplements for livestock feed; food supplements for farm animals; nutritional supplements for veterinary use. Animal foodstuffs; mixed animal feed; formula animal feed; animal feed preparations; yeast for animal fodder.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
31 - Produits agricoles; animaux vivants
Produits et services
Dietary supplements for animals; feed additives for animals; medicated supplements for foodstuffs for animals; feed supplements for veterinary use; feeding stimulants for animals; medicated animal feed; medicated additives for animal foods; probiotic supplements for animals; enzymes for veterinary purposes; enzyme dietary supplements for animals; amino acids for veterinary purposes; protein supplements for animals; bacterial preparations for veterinary purposes; herbal detoxification agents for animals; mineral dietary supplements for animals; nutritional supplements for livestock feed; food supplements for farm animals; nutritional supplements for veterinary use. Animal foodstuffs; mixed animal feed; formula animal feed; animal feed preparations; yeast for animal fodder.
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
Produits et services
Chemical and biochemical products and preparations for use
in (the manufacture of) eye care products, hair care
products, foot care products, lip care products; chemical
and biochemical additives designed for the manufacture of
medicinal and non-medicinal products for the cleaning, care,
treatment and beautification of the skin, foot, lips, body,
face, scalp, hair and hand. Cosmetics and cosmetic preparations, also for eye care, foot
care, lip care, hair care; eye care, hair care, foot care,
lip care products for the prevention of sunburn; sun care
preparations; compounds for skin care after exposure to the
suns rays; preparations and substances for the conditioning,
cleaning, care, treatment and beautification and appearance
of the eye, skin, body, face, scalp, hair, foot, lips and
hand (non-medicated).
The present invention is related to a novel process for production of retinyl acetate in a host cell, particularly oleaginous yeast such as e.g. Yarrowia, wherein the product purity could be increased with reduction of unwanted side-products. Particularly, the novel process comprises fermentation in the presence of ethanol, such as e.g. in a fed-batch fermentation process. Such process is especially useful in a biotechnological process for production of vitamin A.
C12P 23/00 - Préparation de composés contenant un cycle cyclohexène comportant une chaîne latérale non saturée d'au moins dix atomes de carbone liés par des doubles liaisons conjuguées, p.ex. carotènes
